Roivant Sciences(ROIV.US)

Last Updated 19:00:00 ET
longbridge loading

TAT Technologies Posts Upbeat Q1 Earnings, Joins Roivant Sciences, Immunitybio And Other Big Stocks Moving Higher On Wednesday

benzinga_article·
US
TATT
+20.65%
US
.IXIC
+0.92%
US
SLS
+14.36%
benzinga_article·
US
TATT
+20.65%
US
.IXIC
+0.92%
US
SLS
+14.36%

Roivant Sciences Reports Q4 2026 Results: Full Earnings Call Transcript

benzinga_article·
US
ROIV
+13.67%
US
MRNA
+4.83%
US
PBE
+0.89%
benzinga_article·
US
ROIV
+13.67%
US
MRNA
+4.83%
US
PBE
+0.89%

Roivant Sciences shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results.

benzinga_article·
US
ROIV
+13.67%
US
BBH
+0.22%
US
IBB
+1.64%
benzinga_article·
US
ROIV
+13.67%
US
BBH
+0.22%
US
IBB
+1.64%

Roivant Sciences Ltd. FY 2026: Revenue $8.26M, EPS ($0.54) — 10-K Summary

TradingView·
US
ROIV
+13.67%
US
LABU
+9.14%
US
PBE
+0.89%
TradingView·
US
ROIV
+13.67%
US
LABU
+9.14%
US
PBE
+0.89%

Roivant Sciences | 10-K: FY2026 Revenue Misses Estimate at USD 8.26 M

Earnings Watch·
US
ROIV
+13.67%
Earnings Watch·
US
ROIV
+13.67%

Roivant Sciences | 8-K: FY2026 Revenue Misses Estimate at USD 8.26 M

Earnings Watch·
US
ROIV
+13.67%
Earnings Watch·
US
ROIV
+13.67%

Pre-Market Earnings Report for May 20, 2026 : ADI, TJX, LOW, TGT, ROIV, HAS, GDS, VFC, BZ, IMVT, ZIM, ARCO

nasdaq·
US
HAS
-7.76%
US
TGT
-6.13%
US
ROIV
+13.67%
nasdaq·
US
HAS
-7.76%
US
TGT
-6.13%
US
ROIV
+13.67%

Roivant Q4 swings to profit of $355.7 million; revenue falls to $2.52 million

PUBT·
US
ROIV
+13.67%
US
IXJ
+0.39%
US
SBIO
+2.20%
PUBT·
US
ROIV
+13.67%
US
IXJ
+0.39%
US
SBIO
+2.20%

Roivant Sciences Ltd. Stock 12‑Month Price Target Raised to $36.23, Implies 28% Upside

TradingView·
US
ROIV
+13.67%
US
IXJ
+0.39%
US
FBT
+1.27%
TradingView·
US
ROIV
+13.67%
US
IXJ
+0.39%
US
FBT
+1.27%
© 2026 Longbridge｜Disclaimer